000	02111cam  2200301zi 4500
001	9.929987
003	CaOODSP
005	20231106140114
006	m     o  d f
007	cr |n|||||||||
008	231106s2011####oncd    ob   f000 0 eng d
040	|aCaOODSP|beng|erda|cCaOODSP
043	|an-cn---
086	1 |aMR4-170/2011E-PDF
245	00|aCIHR Institute of Health Services and Policy Research : |binternal assessment for 2011 international review.
246	17|aCIHR Institute of Health Services and Policy Research
264	1|a[Ottawa] : |bCanadian Institutes of Health Research = Instituts de recherche en santé du Canada, |c[2011]
300	|a1 online resource (ii, 28 pages) : |bcharts
336	|atext|btxt|2rdacontent
337	|acomputer|bc|2rdamedia
338	|aonline resource|bcr|2rdacarrier
500	|aIssued also in French under title: Institut des services et des politiques de la santé des IRSC : évaluation interne pour l’examen international 2011.
504	|aIncludes bibliographical references (pages 27-28).
520	|a"In the context of Canada’s aging population, rapidly expanding technological possibilities, and increasing consumer demand and fiscal constraints, how should provincial governments decide which drugs to subsidize? What is the most cost-effective means by which they can improve access to primary and specialty health care? How should hospitals and long-term care homes improve the quality and safety of care they provide? How best can the federal government support the effective use of electronic health records? These are some vital questions addressed through the work of the CIHR Institute of Health Services and Policy Research (IHSPR)"--Mandate and context, page 1.
610	20|aInstitute of Health Services and Policy Research (Canada)|xEvaluation.
710	2 |aCanadian Institutes of Health Research, |eissuing body.
775	08|tInstitut des services et des politiques de la santé des IRSC : |w(CaOODSP)9.930003
856	40|qPDF|s969 KB|uhttps://publications.gc.ca/collections/collection_2023/irsc-cihr/MR4-170-2011-eng.pdf